RTRX Retrophin Inc.

-0.66  -3%
Previous Close 23.19
Open 23.29
Price To book 2.92
Market Cap 864824549
Shares 38,385,466
Volume 485,811
Short Ratio 15.55
Av. Daily Volume 328,274

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 dosing has commenced - noted July 25, 2017.
Pantothenate kinase-associated neurodegeneration (PKAN)
NDA filing due 2017.
Liquid ursodeoxycholic acid (L-UDCA)
Primary biliary cholangitis (PBC)
Approved Mar 18 2015
Rare Bile Acid Synthesis Disorders
Phase 3 trial protocol to be finalized with FDA 2H 2017, with initiation due thereafter.
Focal segmental glomerulosclerosis (FSGS)

Latest News

  1. Martin Shkreli's new jailhouse home is 'not where you want to be': Defense lawyer
  2. How Hillary Clinton and Martin Shkreli both wanted somebody else's DNA
  3. Shkreli could get locked up Wednesday if bail revoked over bizarre Hillary Clinton hair stunt
  4. Retrophin to Present at September Investor Conferences
  5. Martin Shkreli seeks to overturn part of his conviction
  6. Prosecutors ask judge to revoke bond of convicted fraudster Martin Shkreli after threats to Clinton
  7. Retrophin Announces Cooperative Research and Development Agreement with NCATS and NGLY1.org to Identify Potential Small Molecule Therapeutics for NGLY1 Deficiency
  8. Pharma bro Martin Shkreli: 'I don't think I'm going to jail'
  9. Retrophin Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
  10. Edited Transcript of RTRX earnings conference call or presentation 9-Aug-17 8:30pm GMT
  11. Sentencing Is When Martin Shkreli's Antics Will Come Back To Haunt Him
  12. Retrophin reports 2Q loss
  13. Retrophin Reports Second Quarter 2017 Financial Results
  14. Investor Network: Retrophin, Inc. to Host Earnings Call
  15. Shkreli's Delight and Crypto Karma
  16. Shkreli sentence turns on antics, investor impact of crime
  17. 'Pharma bro' Shkreli convicted of fraud in U.S. court, assails 'witch hunt'
  18. 'Pharma bro' Martin Shkreli found guilty of 3 of 8 charges, including securities fraud
  19. Martin Shkreli livestreams on YouTube after verdict in trial, talks about doing 'God's work'
  20. Why ‘Pharma Bro’ Martin Shkreli Is Swaggering Into Jail

SEC Filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 171018696
  2. 8-K - Current report 171018023
  3. S-8 - Securities to be offered to employees in employee benefit plans 17898187
  4. 8-K/A [Amend] - Current report 17858499
  5. 8-K/A [Amend] - Current report 17858087
  6. 8-K - Current report 17855821
  7. 10-Q - Quarterly report [Sections 13 or 15(d)] 17815439
  8. 8-K - Current report 17813951
  9. DEF 14A - Other definitive proxy statements 17761637
  10. 8-K - Current report 17761534